Notoginsenoside Fc 产品活性：Notoginsenoside Fc 是从三七叶中分离得到的一种原卟啉二醇 (PPD-) 型皂苷，可有效抵消血小板聚集。Notoginsenoside Fc 可以通过促进自噬促进糖尿病大鼠血管损伤后的内皮细胞再生。 产品来源： https://www.medchemexpress.cn/notoginsenoside-fc.html 研究领域：Autophagy 作用靶点：Autophagy 来源：植物 | 五加科 | 三七 结构分类：萜类 | 三萜 In Vitro: Notoginsenoside Fc (20 μM; for 24 h) markedly upregulates the expression of LC3B and Beclin 1 and downregulated that of p62 in RAOECs. In Vivo: Notoginsenoside Fc (3.5 mg/kg/day) accelerates reendothelialization and alleviates excessive neointimal formation following carotid artery injury in diabetic Sprague-Dawley rats (200±20 g) in vivo. 相关产品：Natural Product Library Plus | Bioactive Compound Library Plus | Natural Product Library | Autophagy Compound Library | Anti-diabetic Compound Library | Glycoside Compound Library | Anti-Cardiovascular Disease Compound Library | Medicine Food Homology Compound Library | Terpenoids Library | Traditional Chinese Medicine Active Compound Library | Food-Sourced Compound Library | Plant-Sourced Natural Product Library | Human Metabolite Library | Coagulation and Anti-coagulation Compound Library | Heterocyclic Compound Library | Cell Death Library | Bioactive Compound Library Max | MG-132 | Rapamycin | 3-Methyladenine | Cisplatin | Cycloheximide | Chloroquine | Doxorubicin hydrochloride | Bafilomycin A1 | Tamoxifen | Olaparib | LY294002 | Paclitaxel | Dexamethasone | Laduviglusib | Forskolin | Actinomycin D | Venetoclax | Bortezomib | Deferoxamine mesylate | Trametinib | Sorafenib | Dorsomorphin | Necrostatin-1 | Retinoic acid | Temozolomide | Gemcitabine | Mdivi-1 | Rotenone | Etoposide | Adezmapimod 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。